AcouSort secures working capital for 2020
AcouSort has obtained loan guarantees of just over SEK 3 million through a consortium consisting of the company’s management, board and founders. The loan guarantee aims to make AcouSort financially
Read MoreNotice of AGM
AcouSort welcomes its share holders to the Annual General Meeting on the 9th of June 2020. The meeting will be held at Medicon Village and starts at 9.00. Find the
Read MoreDelivery of AcouWash to Umeå University
Earlier this year, AcouSort reported having recieved an order from Umeå University regarding a modified AcouWash system. The system has been upgraded to enable separation of circulating tumor cells (CTC)
Read MoreAnalyst Group initiating coverage on AcouSort
Read the full press release in Swedish, here.
Read MorePatent approved for new method to separate cells with sound
AcouSort’s patent application for a new method of separating cells with sound has been approved. The new method makes it possible to separate cells that are similar in size and weight.
Read MoreInterview with CEO
“The market for consumable and semi-consumable blood-plasma separation modules is estimated to grow significantly in the coming years as blood plasma is required for numerous blood-based assays used in health
Read MoreStatus update: Still great interest in the AcouSort technology despite canceled conferences
AcouSort publishes an update on how the company is affected by the current situation. AcouSort is experiencing continuedly growing interest in the company’s products. Although the world situation has changed,
Read MoreAcouSort’s technology can streamline health care – rapidly increasing global interest
AcouSort’s technology uses soundwaves to separate cells and other particles in biological fluids, for example blood samples. The technology enables sample processing to be automated and integrated into diagnostic instruments.
Read MoreYear-end report published
Today, AcouSort released its 2019 Year-end report. Read the full report in Swedish, here.
Read MoreAcouSort performs evaluation assignment for a global life science company
AcouSort will during the spring conduct a comparative study of AcouTrap’s performance compared to other technologies on the market. The assignment is done on behalf of a global life science
Read More